From April 1, 2022 to June 30, 2022, the company has repurchased 5,479,000 shares, representing 4.77% for $93.58 million. With this, the company has completed the repurchase of 7,792,000 shares, representing 6.76% for $143.22 million under the buyback announced on January 24, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.515 USD | -2.40% | -5.94% | -28.36% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.36% | 829M | |
+6.64% | 32.83B | |
+20.31% | 7.73B | |
+23.82% | 3.96B | |
-16.41% | 3.12B | |
-19.48% | 1.38B | |
-30.77% | 1.2B | |
+8.47% | 963M | |
-32.21% | 934M | |
-17.26% | 701M |
- Stock Market
- Equities
- MDRX Stock
- News Veradigm Inc.
- Tranche Update on Allscripts Healthcare Solutions, Inc.'s Equity Buyback Plan announced on January 24, 2022.